0001077183-21-000256.txt : 20211206
0001077183-21-000256.hdr.sgml : 20211206
20211206161642
ACCESSION NUMBER: 0001077183-21-000256
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211206
FILED AS OF DATE: 20211206
DATE AS OF CHANGE: 20211206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mallon Mark
CENTRAL INDEX KEY: 0001763533
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35756
FILM NUMBER: 211473397
MAIL ADDRESS:
STREET 1: C/O IRONWOOD PHARMACEUTICALS, INC.
STREET 2: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEOGENOMICS INC
CENTRAL INDEX KEY: 0001077183
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734]
IRS NUMBER: 742897368
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9490 NEOGENOMICS WAY
CITY: FORT MYERS
STATE: FL
ZIP: 33912
BUSINESS PHONE: 2397680600
MAIL ADDRESS:
STREET 1: 9490 NEOGENOMICS WAY
CITY: FORT MYERS
STATE: FL
ZIP: 33912
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC
DATE OF NAME CHANGE: 19990120
4
1
wf-form4_163882538985808.xml
FORM 4
X0306
4
2021-12-06
0
0001077183
NEOGENOMICS INC
NEO
0001763533
Mallon Mark
9490 NEOGENOMICS WAY
FORT MYERS
FL
33912
1
1
0
0
Chief Executive Officer
Common Stock
2021-12-06
4
P
0
17000
30.63
A
72736
D
Stock Option (Right to Buy)
49.34
2028-04-19
Common Stock
151016.0
151016
D
On April 19, 2021, Mr. Mallon was granted 151,016 stock options. These options vest ratably over the first four anniversary dates of the grant date.
/s/ Mark W. Mallon
2021-12-06